… atrial fibrillation or to a control group. Participants attended local screening centres and those
without a history of atrial fibrillation … was offered if atrial fibrillation was detected or untreated…

… and safety of amiodarone and dronedarone in patients with persistent atrial fibrillation (AF). …
group compared with the amiodarone group. This sample size was based on a first AF/atrial …

… -dose regimens of edoxaban with warfarin in patients with nonvalvular atrial fibrillation (AF).
In this 12-week, parallel-group, multicentre, multinational study, 1,146 patients with AF and …

… -valvular atrial fibrillation (AF). Methods: This was a randomized, parallel group, multicenter,
… There were no clinically relevant differences between treatment groups with respect to the …

… no significant differences between the groups in terms of … of stroke and Embolism Trial in
Atrial Fibrillation) [12]. The results … lower in the rivaroxaban group than in the control group [14]. …

… This study aims to determine efficacy and safety of genotype-guided and clinically guided
dosing of warfarin in atrial fibrillation (AF), deep-vein thrombosis (DVT), and pulmonary …

… This study consisted of a parallel group double-blind … assigned to a treatment or a placebo
group. A block-randomization … was blind to the treatment group allocation until all patients had …

… optimal daily dose regimen of YM150 in subjects with non‐valvular atrial fibrillation (NVAF). …
observed in the 120 mg daily darexaban group compared with warfarin with a reduction in …

… The A3 study is a randomized, controlled, open-label, parallel group trial being conducted
at two centers in Norway, to determine wether treatment of SA with CPAP will reduce the total …

… Design, Setting, and Participants The current study is a secondary analysis of a prospective,
parallel-group, multicenter, single-masked randomized clinical trial (Cryoballoon vs Irrigated …